QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion

Reuters

Oct 01, 2025

QuantumNexis, Subsidiary of <a href="https://laohu8.com/S/HCTI">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion

Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record $(EMR)$ platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2572553644"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572553644\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572553644?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-01 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572553644","market":"us","top_or_hot":-1,"title":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuantumNexis, Subsidiary of <a href=\"https://laohu8.com/S/HCTI\">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record <a href=\"https://laohu8.com/S/EMR\">$(EMR)$</a> platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-01 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      QuantumNexis, Subsidiary of <a href=\"https://laohu8.com/S/HCTI\">Healthcare Triangle</a> Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record <a href=\"https://laohu8.com/S/EMR\">$(EMR)$</a> platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCTI","symbol_name":"Healthcare Triangle, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL2jRQ8t:1","article_id":"2572553644","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572553644","pubTimestamp":1759320129,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion. Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record  platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the ori","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCTI":"Healthcare Triangle, Inc.","BK4167":"医疗保健技术"},"translate_title":"Healthcare Triangle Inc.的子公司QuantumNexis在Ezovion平台上的收入超过2000万美元，全球扩张计划达到3700万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCTI":0.9},"content_text":"QuantumNexis, Subsidiary of Healthcare Triangle Inc., Surpasses $20M in Revenue on Ezovion Platform, Eyes $37M with Global Expansion\n    \n\n        Healthcare Triangle Inc.'s wholly-owned subsidiary, QuantumNexis, has processed over $20 million in end-user revenue through its Ezovion Electronic Medical Record $(EMR)$ platform. The company forecasts this figure will reach $37 million within six months, driven by rapid international expansion and deeper engagement with existing customers. QuantumNexis is also preparing to launch an integrated payment gateway in late 2025, aiming to turn platform activity into recurring revenue and support global scaling throughout 2026.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF87703) on October 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}